Login

Jounce Therapeutics, Inc. SEC Filings

Filed On Filing
14 Feb 2024 SC 13G/A
09 Feb 2024 SC 13G
02 Feb 2024 COWEN FINANCIAL PRODUCTS LLC
15 May 2023 15-12G
05 May 2023 Form 4: Concentra Biosciences, Llc, 10% owner

Acquired 10,000 shares (Other Transaction) ($97.4M)

05 May 2023 Form 4: Tang Kevin C, Director and 2 others

Disposed of 5,300,087 shares (Tender Offer) ($9.81M) · Acquired 10,000 shares (Other Transaction) ($97.4M)

05 May 2023 Form 3: Concentra Biosciences, Llc, 10% owner and 1 other

Holds 36,367,727 shares of Common Stock

05 May 2023 AMENDMENT NO. 4
04 May 2023 EFFECT
04 May 2023 EFFECT
04 May 2023 25-NSE
04 May 2023 Form 4: Salter-Cid Luisa, Director

Disposed of 59,250 Stock Option (Right to Buy) (Disposition to Issuer)

04 May 2023 Form 4: Raythatha Jigar, Director

Disposed of 51,400 Stock Option (Right to Buy) (Disposition to Issuer)

04 May 2023 Form 4: Murray Richard /CA/, Director

Disposed of 188,778 shares (Tender Offer) · Disposed of 1,883,269 Stock Option (Right to Buy) (Disposition to Issuer)

04 May 2023 Form 4: Karsen Perry A, Director

Disposed of 5,000 shares (Tender Offer) · Disposed of 172,590 Stock Option (Right to Buy) (Disposition to Issuer)

04 May 2023 Form 4: Kamen Robert, Director

Disposed of 94,850 shares (Tender Offer) · Disposed of 91,490 Stock Option (Right to Buy) (Disposition to Issuer)

04 May 2023 Form 4: Iannone Robert, Director

Disposed of 74,950 Stock Option (Right to Buy) (Disposition to Issuer)

04 May 2023 Form 4: Duncan Barbara Gayle, Director

Disposed of 125,761 Stock Option (Right to Buy) (Disposition to Issuer)

04 May 2023 Form 4: Drapkin Kimberlee C, President, CFO and Treasurer

Disposed of 66,018 shares (Tender Offer) · Disposed of 586,270 Stock Option (Right to Buy) (Disposition to Issuer)

04 May 2023 Form 4: Diaz Luis, Director

Disposed of 104,363 Stock Option (Right to Buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support